Eucrisa (Crisaborole) for Eczema

Overview
Eucrisa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat mild to moderate atopic dermatitis in people aged 2 and older. Eucrisa is also known by its drug name, crisaborole.

Eucrisa is a topical phosphodiesterase 4 (PDE4) inhibitor. Eucrisa is believed to work by suppressing immune system activity.

How do I take it?
Prescribing information states that Eucrisa is applied topically to the affected area twice daily.

Eucrisa comes in the form of an ointment.

Side effects
The FDA-approved label for Eucrisa lists common side effects including pain at the application site.

Rare but serious side effects for Eucrisa include hypersensitivity reactions, which may include hives, redness, and swelling.

For more details about this treatment, visit:

Eucrisa — Pfizer
www.eucrisa.com

Prescription Topicals — National Eczema Association
www.nationaleczema.org/eczema/treatment/topicals